Clinical Trial Update: Prevalence & Risk Factors of De Novo (MASLD) Post Liver Transplant

View source ↗

Summary

Study assessing prevalence and risk factors for de novo MASLD in post-liver transplant patients. The trial status is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Metabolic Dysfunction-associated Steatotic Liver Disease

Snippet

Sponsor: Assiut University | Conditions: Post Liver Tranзplant | Status: NOT_YET_RECRUITING